
ENPP1 inhibitor with ultralong drug-target residence time as an innate immune checkpoint blockade cancer therapy
Songnan Wang, Randolph M. Johnson, Jacqueline A. Carozza, Daniel Fernandez, Jan Scicinski, Neil A. Verity, Rachel Mardjuki, Xujun Cao, Yingjie Guo, Jacqueline Papkoff, Nigel Ray, Lingyin Li





































